TrialEndocrinology and metabolism (Seoul, Korea)2019

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria.

Yun Mi Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.